CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 88 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q1 2021. The put-call ratio across all filers is 0.04 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $722,000 | +0.3% | 6,100 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $720,000 | +140.0% | 6,100 | +125.9% | 0.00% | – |
| Q3 2020 | $300,000 | +8.7% | 2,700 | 0.0% | 0.00% | – |
| Q2 2020 | $276,000 | -5.2% | 2,700 | 0.0% | 0.00% | -100.0% |
| Q1 2020 | $291,000 | -7.3% | 2,700 | 0.0% | 0.00% | – |
| Q4 2019 | $314,000 | +1.6% | 2,700 | 0.0% | 0.00% | – |
| Q3 2019 | $309,000 | +54.5% | 2,700 | +28.6% | 0.00% | – |
| Q2 2019 | $200,000 | +4.2% | 2,100 | 0.0% | 0.00% | – |
| Q1 2019 | $192,000 | +20.8% | 2,100 | 0.0% | 0.00% | – |
| Q4 2018 | $159,000 | +71.0% | 2,100 | +79.9% | 0.00% | – |
| Q3 2018 | $93,000 | +158.3% | 1,167 | +218.0% | 0.00% | – |
| Q2 2018 | $36,000 | -96.8% | 367 | -97.3% | 0.00% | -100.0% |
| Q1 2018 | $1,115,000 | -67.5% | 13,757 | -68.4% | 0.00% | -60.0% |
| Q4 2017 | $3,426,000 | – | 43,502 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|